Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BioAtla Inc
About BCAB
BioAtla, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of solid tumor cancer. The Company’s product candidates include Mecbotamab vedotin (BA3011), Ozuriftabmab vedotin (BA3021), evalstotug (BA3071), and BA3182. Its lead product candidate, BA3011, is a conditionally active biologics (CAB) antibody-drug conjugate that targets AXL, which is a protein kinase receptor. The BA3071 is a potential therapeutic for multiple solid tumor types, including soft tissue and bone sarcoma, and non-small cell lung cancer. BA3021 is developing a CAB antibody drug conjugate directed against a receptor tyrosine kinase such as orphan receptor 2 (ROR2). BA3071 is a CAB anti-CTLA-4 antibody that is being developed as a therapeutic for multiple solid tumor indications. BA3182 is designed with an EpCAM binding domain and a CD3 binding domain, both binding domains with CAB activity (Dual-CAB), for the treatment of advanced adenocarcinoma.
Find out what a historical investment in BioAtla Inc would be worth today using our BCAB stock calculator.
Market Capitalisation
$7.09M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
27.45K
High today
$4.77
Low today
$4.22
Open price
$4.27
52-week high
$71.50
52-week low
$3.92
Ready to start your investing journey with Stake?
Open an accountHow do I buy BCAB shares in Australia?
Buying BCAB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BioAtla Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BCAB
What is the ticker symbol of BioAtla Inc?
The ticker symbol for BioAtla Inc is BCAB.
How much is one share of BCAB?
One share of BCAB is valued at $4.37 as of 17 May 2026.
What is the market capitalisation of BioAtla Inc BCAB?
As of 17 May 2026 BioAtla Inc has a market cap of $7.09M.
What is the 52-week high for BioAtla Inc stock?
The BioAtla Inc 52-week high stock price is $71.50.
What is the 52-week low for BioAtla Inc stock?
The BioAtla Inc 52-week low stock price is $3.92.
Can I buy BCAB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BCAB shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BCAB on Stake
- Buy BCAB from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BCAB from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BCAB related stocks